Related references
Note: Only part of the references are listed.More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer
Firas Abdollah et al.
EUROPEAN UROLOGY (2015)
Prospective Comparison of F-18-Fluoromethylcholine Versus Ga-68-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Joshua J. Morigi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography
S. Hijazi et al.
PROSTATE (2015)
Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project
K. C. Cary et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Removal of Limited Nodal Disease in Patients Undergoing Radical Prostatectomy: Long-Term Results Confirm a Chance for Cure
Roland Seiler et al.
JOURNAL OF UROLOGY (2014)
Performance evaluation of the Ingenuity TF PET/CT scanner with a focus on high count-rate conditions
Jeffrey A. Kolthammer et al.
PHYSICS IN MEDICINE AND BIOLOGY (2014)
American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale
H. Ballentine Carter
BJU INTERNATIONAL (2013)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Mapping of Pelvic Lymph Node Metastases in Prostate Cancer
Steven Joniau et al.
EUROPEAN UROLOGY (2013)
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis
Laura Evangelista et al.
EUROPEAN UROLOGY (2013)
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
Alberto Briganti et al.
EUROPEAN UROLOGY (2012)
Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases
Tom Budiharto et al.
EUROPEAN UROLOGY (2011)
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Caroline M. A. Hoeks et al.
RADIOLOGY (2011)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
11C-Choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer:: Comparison with clinical staging nomograms
Riccardo Schiavina et al.
EUROPEAN UROLOGY (2008)
Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: Implications for staging systems and predictive models
DI Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
